News
Latest News and Press Releases
Nissan Chemical and Axcelead DDP Enter into Business Partnership to Support Drug Discovery Research for RNA Therapeutics
Tokyo and Kanagawa, Japan, July 18, 2025 — Nissan Chemical Corporation (HQ: Tokyo, Japan; Representative Director, President...
Axcelead DDP and Superluminal Announce the Intent to Collaborate on Drug Discovery Targeting Specific Molecular Mechanisms, continuing a productive relationship
Kanagawa, Japan and Boston, MA, USA – Jun 23, 2025– Axcelead Drug Discovery Partners, Inc. (HQ: Fujisawa,...
LOTTE BIOLOGICS, Axcelead Drug Discovery Partners, Inc., and Kanaph Therapeutics Inc. Sign 3-Way MOU to Develop ADC Toolbox
- Exploring expansion of ADC services through synergy in ADC modality business via trilateral agreement - Aims...
The results of joint research with Luxna Biotec, Inc published in “Nucleic Acid Therapeutics”
Hepatotoxicity Reduction Profiles of Antisense Oligonucleotides Containing Amido-Bridged Nucleic Acid and 2′-O,4′-C-Spirocyclopropylene Bridged Nucleic Acid Publication Amide-bridged...
Axcelead DDP Enters into Drug Discovery Service Agreement with Astellas for Targeted Protein Degraders
December 26, 2024 - Axcelead Drug Discovery Partners, Inc. (HQ: Fujisawa, Kanagawa, Japan; “Axcelead DDP”) announced today...